1 / 47

Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, 1987-2005

Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, 1987-2005. *1 patient in year transplant 2001 with no death date **2 patients with missing outcome status and 1 patient with unknown outcome status

fagan
Download Presentation

Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, 1987-2005

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, 1987-2005 *1 patient in year transplant 2001 with no death date **2 patients with missing outcome status and 1 patient with unknown outcome status *Out of 1048 patients who were transplanted, there were 40 patients with early death before day 30 of transplant

  2. Figure 1.1.1: Stock and Flow of Blood and Marrow Transplantation, 1987-2005 New patients Alive at 31st Dec 700 600 500 400 Number of patients 300 200 100 0 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 1988 1990 1992 1994 1996 1998 2000 2002 2004 Year

  3. Rate, pmp 6 5 4 New transplant rate, pmp 3 2 1 0 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 Year Table 1.1.2: New Transplant Rate per million population (pmp), 1987-2005 Figure 1.1.2: New Transplant Rate per million population (pmp), 1987-2005

  4. Table 1.1.3: Centre distribution (SDP), 1987-2005

  5. Table 1.1.3: Centre distribution (SDP), 1987-2005

  6. Figure 1.1.3: Centre distribution (SDP), 1987-2005 KLA KLP UKM SJA UMA UMP 120 110 100 90 80 70 60 Number 50 40 30 20 10 0 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 Year

  7. Table 1.2.1: Gender distribution, 1987-2005

  8. Figure 1.2.1: Gender distribution, 1987-2005 Male Female 100 80 60 Percent 40 20 0 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 Year

  9. Table 1.2.2: Ethnic group distribution, 1987-2005

  10. Table 1.2.2: Ethnic group distribution, 1987-2005

  11. Figure 1.2.2: Ethnic group distribution, 1987-2005 Malay Chinese Indian Bumiputra Sarawak Others Bumiputra Sabah 100 90 80 70 60 Percent 50 40 30 20 10 0 1987 1989 1991 1993 1997 1999 2001 2003 2005 1995 Year

  12. Table 1.2.3: Age distribution, 1987-2005

  13. Table 1.2.3: Age distribution, 1987-2005 *Age=date of transplant – date of birth

  14. 0-9 years 10-19 years 20-39 years 40-59 years >=60 years 100 90 80 70 60 Percent 50 40 30 20 10 0 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 Year Figure 1.2.3: Age distribution, 1987-2005

  15. Table 1.2.4: Primary Diagnosis, 1987-2005

  16. Table 1.2.4: Primary Diagnosis, 1987-2005

  17. Table 1.2.4: Primary Diagnosis, 1987-2005

  18. Table 1.3.1: Graft number, 1987-2005

  19. Figure 1.3.1: Graft number, 1987-2005 Graft number 1 Graft number 2 Graft number 3 100 80 60 Percent 40 20 0 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 Year

  20. Table 1.3.2: Type of transplant, 1987-2005 *6 patients with syngeneic type of transplant

  21. Allogeneic + Syngeneic Autologous 140 120 100 80 Number 60 40 20 0 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 1988 1990 1992 1994 1996 1998 2000 2002 2004 Year Figure 1.3.2: Type of transplant, 1987-2005

  22. Table 1.3.3: Type of transplant by Centre, 1987-2005

  23. Allogeneic + Syngeneic Autologous 280 260 240 220 200 180 160 Number 140 120 100 80 60 40 20 0 KLA UKM UMA GMC SJP KLP SJA UMP LWE Centre Figure 1.3.3: Type of transplant by Centre, 1987-2005

  24. Table 1.3.4: Transplant source, 1987-2005

  25. Figure 1.3.4: Transplant source, 1987-2005 Marrow PBSC/ Marrow+ PBSC Cord blood/ Marrow + cord 140 120 100 80 Number 60 40 20 0 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 Year

  26. Table 1.3.5: HLA Match, 1987-2005 *excluding autologous

  27. Table 1.3.6: Allogeneic Donor Relationship, 1987-2005 *excluding autologous, including syngeneic

  28. Table 1.4.1: Cause of Death, 1987-2005

  29. Table 1.4.1: Cause of Death, 1987-2005 *3 patients with missing cause of death reported

  30. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Year 1987-1992 Year 1993-1998 Year 1999-2005 Figure 1.4.1: Patient survival by year of transplant, 1987-2005

  31. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Male Female Figure 1.4.2: Patient survival by gender, 1987-2005

  32. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years 0-9 years 10-19 years 20-39 years >=40 years Figure 1.4.3: Patient survival by age group, 1987-2005

  33. 0 1 2 3 4 5 6 7 8 9 10 11 Figure 1.4.4: Patient survival by type of transplant, 1987-2005 1.00 0.75 0.50 Cumulative survival 0.25 0.00 12 13 14 15 16 17 18 19 20 Duration in years Allogeneic + Syngeneic Autologous

  34. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Allogeneic Autologous Figure 1.5.1: Disease-free survival for Acute Myeloid Leukaemia, 1987-2005 (Allogeneic vs. Autologous)

  35. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Allogeneic Figure 1.5.2: Disease-free survival for Acute Lymphoblastic Leukaemia, 1987-2005 (Allogeneic)

  36. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Allogeneic Figure 1.5.3: Disease-free survival for Thalassaemia, 1987-2005 (Allogeneic)

  37. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Allogeneic Autologous Figure 1.5.4: Disease-free survival for Non-Hodgkin’s Lymphoma, 1987-2005 (Allogeneic vs. Autologous)

  38. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Autologous Figure 1.5.5: Disease-free survival for Hodgkin’s Disease, 1987-2005 (Autologous)

  39. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Allogeneic Figure 1.5.6: Disease-free survival for Chronic Myeloid Leukaemia, 1987-2005 (Allogeneic)

  40. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Allogeneic Figure 1.5.7: Disease-free survival for Aplastic Anaemia, 1987-2005 (Allogeneic)

  41. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Paediatric Adult Figure 1.5.8: Disease-free survival by age group for Acute Myeloid Leukaemia, 1987-2005 Paediatric is defined as age 18 years and adult age >18 years

  42. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Paediatric Adult Figure 1.5.9: Disease-free survival by age group for Acute Lymphoblastic Leukaemia, 1987-2005 Paediatric is defined as age 18 years and adult age >18 years

  43. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Paediatric Figure 1.5.10: Disease-free survival by age group for Thalassaemia, 1987-2005 * No adult cases reported for Thalassaemia. Paediatric is defined as age 18 years and adult age >18 years

  44. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Paediatric Adult Figure 1.5.11: Disease-free survival by age group for Non-Hodgkin’s Lymphoma, 1987-2005 Paediatric is defined as age 18 years and adult age >18 years

  45. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Paediatric Adult Figure 1.5.12: Disease-free survival by age group for Hodgkin’s Disease, 1987-2005 Paediatric is defined as age 18 years and adult age >18 years

  46. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Paediatric Adult Figure 1.5.13: Disease-free survival by age group for Chronic Myeloid Leukaemia, 1987-2005 Paediatric is defined as age 18 years and adult age >18 years

  47. 1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Duration in years Paediatric Adult Figure 1.5.14: Disease-free survival by age group for Aplastic Anaemia, 1987-2005 Paediatric is defined as age 18 years and adult age >18 years

More Related